Literature DB >> 415653

Respiratory syncytial virus infection in adults: clinical, virologic, and serial pulmonary function studies.

W J Hall, C B Hall, D M Speers.   

Abstract

We prospectively studied 10 previously healthy adults who developed an acute respiratory illness while working in an infants' ward during a community outbreak of respiratory syncytial virus infection. In addition to clinical and viral evaluation, total respiratory resistance before and after carbachol aerosol inhalation was measured. All 10 subjects had respiratory syncytial virus infection documented by viral isolation, and all developed pronounced cough, nasal congestion, and fever. Eight subjects missed work for an average of 6 days. In all 10 patients, the total respiratory resistance was significantly elevated through 8 weeks. Altered airway reactivity, characterized by exaggerated responses of pulmonary resistance to carbachol challenge, was also observed through the first 8 weeks of evaluation. In this group, respiratory syncytial virus produced a protracted illness associated with appreciable morbidity. The pathophysiologic mechanism of this illness in part appeared to arise from altered airway reactivity.

Entities:  

Mesh:

Year:  1978        PMID: 415653     DOI: 10.7326/0003-4819-88-2-203

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  60 in total

Review 1.  The respiratory syncitial virus and its role in acute bronchiolitis.

Authors:  M L Everard; A D Milner
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

Review 2.  Acute bronchiolitis in infancy: treatment and prognosis.

Authors:  A D Milner; M Murray
Journal:  Thorax       Date:  1989-01       Impact factor: 9.139

3.  Nonvalue of sputum culture in the management of lower respiratory tract infections.

Authors:  J R Lentino; D A Lucks
Journal:  J Clin Microbiol       Date:  1987-05       Impact factor: 5.948

Review 4.  Viral and host factors in human respiratory syncytial virus pathogenesis.

Authors:  Peter L Collins; Barney S Graham
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

Review 5.  Respiratory viral infections in hematopoietic stem cell and solid organ transplant recipients.

Authors:  S Samuel Weigt; Aric L Gregson; Jane C Deng; Joseph P Lynch; John A Belperio
Journal:  Semin Respir Crit Care Med       Date:  2011-08-19       Impact factor: 3.119

6.  In vivo inhibition of respiratory syncytial virus by ribavirin.

Authors:  J F Hruska; P E Morrow; S C Suffin; R G Douglas
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

Review 7.  Epidemiology and prevention of pediatric viral respiratory infections in health-care institutions.

Authors:  D A Goldmann
Journal:  Emerg Infect Dis       Date:  2001 Mar-Apr       Impact factor: 6.883

Review 8.  The diagnosis of viral respiratory disease in older adults.

Authors:  H Keipp Talbot; Ann R Falsey
Journal:  Clin Infect Dis       Date:  2010-03-01       Impact factor: 9.079

9.  Cytokine (IL-8, IL-6, TNF-alpha) and soluble TNF receptor-I release from human peripheral blood mononuclear cells after respiratory syncytial virus infection.

Authors:  R Arnold; B König; H Galatti; H Werchau; W König
Journal:  Immunology       Date:  1995-07       Impact factor: 7.397

10.  Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants.

Authors:  Asunción Mejías; Octavio Ramilo
Journal:  Biologics       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.